Tag archive for ‘Comparison of three month data from JULIET trial with ZUMA-1’
Novartis Releases Three Month Interim Data for JULIET Trial of CTL-019 in r/r DLBCL
Key Points: Comparison of three month data for CTL-019 in the JULIET trial with Axi-Cel in ZUMA-1 indicates that safety and efficacy are remarkably comparable for the two products. At this point, there seems to be no differentiation between the two. Some analysts are strong propoents of Kite raised the issue that Novartis had manufacturing […]